A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
Clinical trial NCT05926960 · TERMINATED
Trial details
- NCT number
- NCT05926960
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2026-02-02
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.